Webinar | Enterprise Imaging| March 11, 2021

LUNCH & LEARN: Achieving Digital Imaging Maturity: Enterprise Imaging and the HIMSS DIAM Assessment

This Philips-sponsored Lunch & Learn will took place April 7, 2021. You can watch webinar on-demand here.

This Philips-sponsored Lunch & Learn will take place April 7, 2021, at noon CST

Now more than ever, technology and analytics are driving improvements in healthcare. Organizations focused on measuring and advancing their digital imaging capabilities find themselves at a strategic advantage, and are better positioned to respond to market stressors, like the COVID-19 pandemic, as they arise.

In this Lunch & Learn session sponsored by Philips, a panel of experts will discuss how the HIMSS Digital Imaging Maturity Model (DIAM) can help organizations identify areas of opportunity, pivot when needed, and invest in the right advancements in their overall enterprise imaging strategy.

This Philips-sponsored Lunch & Learn took place April 7, 2021. You can watch the archived version here.

Learning Objectives

Using the eight-stage HIMSS Digital Imaging Adoption Model (DIAM) gap assessment, a panel of experts will discuss:

  • How investing in an overall enterprise imaging strategy can help organizations be better prepared to respond
  • How a maturity gap assessment can help you identify and adopt the right digital strategy to improve health outcomes
  • How adopting integrated technologies can streamline workflows, provide seamless access, and support patient engagement

This Philips-sponsored Lunch & Learn took place April 7, 2021You can watch the archived version here.

Speakers

Cheryl Petersilge, M.D., MBA
President and Founder
Vidagos

Cheryl Petersilge, M.D., MBA, is President and Founder of Vidagos, an enterprise imaging strategy firm. A respected physician, imaging leader, and innovative engineer, Petersilge provides extensive expertise as a pioneer in enterprise imaging with deep knowledge in healthcare informatics.

As an internationally known radiologist and highly regarded physician leader at the Cleveland Clinic, Petersilge held numerous Chair and Medical Director positions in radiology and information technology. Petersilge was at the forefront of the movement to design best practices and establish cutting-edge systems that informed the Clinic’s rise to global leadership in enterprising imaging.

Petersilge is recognized among the top professionals in her field, having been selected as one of three U.S. representatives on the HIMSS International Center for Excellence for development of the Digital Imaging Adoption Model (DIAM). She leads the HIMSS-SIIM Enterprise Imaging Community Photodocumentation Workgroup. She is the past president of the Society of Skeletal Radiology and provides leadership for numerous professional organizations and advisory boards.

 

James E. Gaston, MBA, FHIMSS
Senior Director, Healthcare Advisory Services Group
HIMSS Analytics

James Gaston has been working in healthcare information technology for over 29+ years with experience in hospital, healthcare insurance, vendor, and consulting services. Gaston is an expert in healthcare analytics providing education and industry insight through a variety of forums, including the American College of Healthcare Executives. On behalf of HIMSS Analytics he manages the globally oriented Adoption Model for Analytics Maturity (AMAM) and the Continuity of Care Maturity Model (CCMM), serving as an consulting resource for HIMSS worldwide. As a Senior Director within Healthcare Advisory Services of HIMSS Analytics Gaston coalesces industry insights into practical guidelines for healthcare organizations to chart their analytics, at-risk payment, and continuity of care strategies.

Gaston has a Master’s in Business Administration and a Bachelor’s of Science degree in Computer Science Engineering, is a HIMSS Fellow, and is an instructor for the American College of Healthcare Executives. Gaston is also enjoys mountain biking and ultra running.

Sponsor Profile

Philips is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips partners with healthcare providers, IT and clinical teams across the enterprise, helping them to produce meaningful, data-driven insights for clinical and operational decision-making, as well as to adopt innovations through the use of maturity models to drive digital transformation.

Register for the Lunch & Learn here.

Related Content

Cina Chest is part of Avicenna’s CINA family of AI tools that support the treatment of emergencies, including CINA HEAD, its FDA-cleared and CE-Marked solution that supports the detection and triage of stroke and neurovascular emergencies.
News | Artificial Intelligence | June 03, 2021
June 3, 2021 — Medical imaging AI specialist Avicenna.AI announced
International medical imaging IT and cybersecurity company Sectra will install its solution for digital pathology at Institut Curie, one of the most recognized and prestigious cancer centers in France.
News | Enterprise Imaging | May 24, 2021
May 24, 2021 — International medical imaging IT and cybersecurity company ...
The Healthcare Information and Management Systems Society, Inc. (HIMSS) 2021 Conference, scheduled for August 9-13 in Las Vegas, will be one of the first to take a step back to normalcy

Getty Images

News | HIMSS | May 17, 2021
May 17, 2021 — It looks like in-person conferences are making a comeback.
Artificial intelligence (AI)-driven healthcare has potential to transform medical decision-making and treatment, but AI algorithms must be thoroughly tested and continuously monitored to avoid unintended consequences to patients. In JAMA Network Open, Regenstrief Institute President Peter Embí, M.D., calls for algorithmovigilance (a term he coined for scientific methods and activities relating to evaluation, monitoring, understanding and prevention of adverse effects of algorithms in healthcare) to address

Artificial intelligence (AI)-driven healthcare has potential to transform medical decision-making and treatment, but AI algorithms must be thoroughly tested and continuously monitored to avoid unintended consequences to patients. In JAMA Network Open, Regenstrief Institute President Peter Embí, M.D., calls for algorithmovigilance (a term he coined for scientific methods and activities relating to evaluation, monitoring, understanding and prevention of adverse effects of algorithms in healthcare) to address inherent biases in healthcare algorithms and their deployment. Image courtesy of Regenstrief Institute

News | Artificial Intelligence | May 14, 2021
May 14, 2021 — Artificial intelligence
Herman Oosterwijk

Herman Oosterwijk

News | Artificial Intelligence | May 13, 2021
May 13, 2021 — Laurel Bridge Software, a provider of ...